[1. Steinberg D, Lewis A, Conner Memorial Lecture. Oxidative modification of LDL and atherogenesis. Circulation. 1997; 95:1062-71.10.1161/01.CIR.95.4.1062]Search in Google Scholar
[2. Parks EJ, German JB, Davis PA, et al. Reduced oxidative susceptibility of LDL from patients participating in an intensive atherosclerosis treatment program. Am J Clin Nutr. 1998; 68:778-85.10.1093/ajcn/68.4.778]Search in Google Scholar
[3. Chan CA. Vitamin E and Atherosclerosis. The Journal of Nutrition. 1998; 128:1593-6.10.1093/jn/128.10.1593]Search in Google Scholar
[4. Dutta A, Dutta KS. Vitamin E and its Role in the Prevention of Atherosclerosis and Carcinogenesis: A Review. Journal of the American College of Nutrition. 2003; 22:258-68.10.1080/07315724.2003.10719302]Open DOISearch in Google Scholar
[5. Upston JM, Terentis AC, Stocker R. Tocopherolmediated peroxidation of lipoproteins: implications for vitamin E as a potential anti-atherogenic supplement. The FASEB Journal. 1999; 13:977-94.10.1096/fasebj.13.9.977]Search in Google Scholar
[6. Regnstrom J, Nilsson J, Moldeus P, Strom K, Bavenholm P, Tornvall P , Hamsten A. Inverse relation between the concentration of low-density-lipoprotein vitamin E and severity of coronary artery disease. Am J Clin Nutr. 1996; 63:377-85.10.1093/ajcn/63.3.377]Search in Google Scholar
[7. Gey KF, Pushka P, Jordan P, Moser UK. Inverse correlation between plasma vitamin E and mortality from ischemic heart diseases in cross cultural epidemiology. Am J Clin Nutr. 1991; 53:326-34.10.1093/ajcn/53.1.326S]Search in Google Scholar
[8. Feki M, Souissi M, Mokhtar E, Hsairi M, Kaabachi N, Antebi H, et al. Vitamin E and coronary heart disease in Tunisians. Clinical Chemistry. 2000; 46:1401-5.10.1093/clinchem/46.9.1401]Search in Google Scholar
[9. Haidari M, Javadi E, Kadkhodaee M, Sanati A. Enhanced susceptibility to oxidation and diminished vitamin E content of LDL from patients with stable coronary artery disease. Clinical Chemistry. 2001; 47: 1234-40.10.1093/clinchem/47.7.1234]Search in Google Scholar
[10. Salonen JT, Salonen R, Penttila I, Herranen J, Jauhiainen M, Kantola M. Serum fatty acids, apolipoproteins, selenium and vitamin antioxidants and risk of death from coronary artery diseases. Am J Cardiol. 1985; 56:226-31.10.1016/0002-9149(85)90839-2]Search in Google Scholar
[11. Kok F, De Bruijn AM, Vermeeren R, Hoffman A, Van Laar A, De Bruin M, et al. Serum selenium and vitamin antioxidants and cardiovascular mortality. Am J Clin Nutr. 1987; 45:462-8.10.1093/ajcn/45.2.4623812345]Search in Google Scholar
[12. Street DA, Comstock GW, Salkled RM, Schep W, Klag MJ. A population-based case-control study of the association between serum antioxidant and myocardial infarction. Am J Epidemiol. 1991; 134: 719-20.]Search in Google Scholar
[13. Ohrvall M, Berghund L, Salmmeri I, Lithell H, Aro A, Vessby B. The serum cholesterol and essential fatty acid composition but not alpha tocopherol predicts the development of myocardial infarction in 50-yearold-men: a 9 years follow up. Atherosclerosis. 1996;127:65-71.10.1016/S0021-9150(96)05936-9]Search in Google Scholar
[14. Ghayour-Mobarhan M, Sahebkar AH, Livingstone C, Wang T, Lamb D, Ferns G. An investigation of the relationship between serum vitamin E status and coronary risk factors in dyslipidaemic patients. Iranian Journal of Biomedical Science. 2008; 10:206-15.]Search in Google Scholar
[15. Sarraf-Zadegan N, Seyed-Tabatabaei FA, Bashardoost N, Malek A, Totonchi M, Habibi HR, et al. The prevalence of coronary artery disease in an urban population in Isfahan, Iran. Acta Cardiol. 1999: 54:257-63.]Search in Google Scholar
[16. Hatmi ZN, Tahvildari S, Gafarzadeh Motlag A, Sabouri Kashani A. Prevalence of coronary artery disease risk factors in Iran: a population based survey. BMC cardiovascular Disorder [on line] 2007 [cited 2007]; 7:32, Available from: http://www.biomedcentral.com/1471-2261/7/32.10.1186/1471-2261-7-32]Search in Google Scholar
[17. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med. 1993; 328:1450-6.10.1056/NEJM199305203282004]Search in Google Scholar
[18. Rajasekhar D, Srinivasa Rao P, Latheef S, Saibaba K, Subramanyam G. Association of serum antioxidants and risk of coronary heart disease in South Indian population. Indian Journal of Medical Sciences. 2004; 58:465-71.]Search in Google Scholar
[19. Salonen JT, Salonen R, Penttila I, et al. Serum fatty acids, apolipoproteins, selenium and vitamin antioxidants and the risk of death from coronary artery disease. Am J Cardiol. 1985; 56:226-31.10.1016/0002-9149(85)90839-2]Search in Google Scholar
[20. Kok FJ, de Bruijn AM, Vermeeren R, et al. Serum selenium, vitamin antioxidants and cardiovascular mortality: A 9-year follow-up study in the Netherlands. Am J Clin Nutr. 1987; 45:462-8.10.1093/ajcn/45.2.462]Search in Google Scholar
[21. Evans RW, Shaten BJ, Day BW, Kuller LH. Prospective association between lipid soluble antioxidants and coronary heart disease in men. The Multiple Risk Factor Intervention Trial. Am J Epidemiol. 1998; 147:180-6.10.1093/oxfordjournals.aje.a0094329457009]Search in Google Scholar
[22. Kushi LH, Folsom AR, Prineas RJ, Mink PJ, Wu Y, Bostick RM. Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women. N Engl J Med. 1996; 334:1156-62.10.1056/NEJM1996050233418038602181]Search in Google Scholar
[23. Pham DQ, Plakogiannis R. Vitamin E supplementation in cardiovascular disease and cancer prevention. The Annals of Pharmacotherapy. 2005; 39:1870-78.10.1345/aph.1G21116189282]Open DOISearch in Google Scholar
[24. Riccioni G, Bucciarelli T, Mancini B, Corradi F, Di Ilio C, Mattei PA , D’Orazio N. Antioxidant Vitamin Supplementation in Cardiovascular Diseases. Annals of Clinical Laboratory Science. 2007; 37:89-95.]Search in Google Scholar
[25. Schwenke DC, Rudel LL, Sorci-Thomas MG, Thomas MJ. α-tocopherol protects against diet induced atherosclerosis in New Zealand white rabbits. Journal of Lipid Research. 2002; 43:1927-38.10.1194/jlr.M200261-JLR200]Search in Google Scholar
[26. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSIPrevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell’Infartomiocardico. Lancet. 1999; 354:447-55.10.1016/S0140-6736(99)07072-5]Search in Google Scholar
[27. Collaborative Group of the Primary Prevention Project. Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomized trial in general practice. Lancet 2001; 357:89-95.10.1016/S0140-6736(00)03539-X]Search in Google Scholar
[28. Yusuf S, Dagenais G, Pogue J, Bosch J, Sleight P. Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 2000; 342:154-60.]Search in Google Scholar
[29. Miller III ER, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LJ, Guallar E. Meta-Analysis: High-Dosage Vitamin E Supplementation May Increase All-Cause Mortality. Annals of Internal Medicine. 2005; 142: 37-46.10.7326/0003-4819-142-1-200501040-0011015537682]Search in Google Scholar
[30. Kinlay S, Behrendt D, Fang JC, Delagrange D, Morrow J, Witztum JL, Rifai N, Selwyn AP, Creager MA, Ganz P. Long-Term Effect of Combined Vitamins E and C on Coronary and Peripheral Endothelial Function. J Am Coll Cardiol. 2004; 43:629-34.10.1016/j.jacc.2003.08.05114975474]Search in Google Scholar
[31. Keith ME, Keith ME, Jeejeebhoy KN, Langer A, Kurian R, Barr A, et al. A controlled clinical trial of vitamin E supplementation in patients with congestive heart failure. Am J Clin Nutr 2001; 73:219-24.10.1093/ajcn/73.2.21911157316]Search in Google Scholar
[32. Ferns GAA. Multiple step-variable pathway hypothesis: A reason why predictions fail in atherosclerosis. Medical Hypotheses. 2008; 71:923-6.10.1016/j.mehy.2008.07.01418762385]Search in Google Scholar
[33. Stocker R, Keaney JF. Role of oxidative modifications in atherosclerosis. Physiol Rev. 2004; 84:1381-478.10.1152/physrev.00047.200315383655]Search in Google Scholar
[34. Manson JE, Bassuk SS, Stampfer MJ. Does vitamin E supplementation prevent cardiovascular events? J Womens Health (Larchmt). 2003; 12:123-36.10.1089/15409990332157651012741415]Open DOISearch in Google Scholar
[35. Reitman A, Friedrich I, Ben-Amotz A, Levy Y. Low Plasma Antioxidants and Normal Plasma B Vitamins and Homocysteine in Patients with Severe Obesity. IMAJ. 2002; 4:590-3.]Search in Google Scholar
[36. Brown M. Do vitamin E and fish oil protect against ischemic heart disease? Lancet. 1999; 354:441-2.]Search in Google Scholar
[37. Schectman G, Byrd JC, Gruchow HW. The influence of smoking on vitamin C status in adults. Am J Public Health. 1989; 79:158-62.10.2105/AJPH.79.2.158]Open DOISearch in Google Scholar
[38. Karajibani M, Hashemi M, Montazerifar F, Bolouri A, Dikshit M.The status of glutathione peroxidase, superoxide desmutase, vitamins A, C, E and malondialdehyde in patients with cardiovascular disease in Zahedan, South Iran. J Nutri Sci Vitaminol. 2009; 55:309-16.10.3177/jnsv.55.30919763031]Open DOISearch in Google Scholar
[39. Aliabadi M, Kimiagar M, Ghayour-Mobarhan M, Shakeri MT, Nematy M, Ilaty AA, et al. Prevalence of malnutrition in free living elderly people in Iran: a crosssectional study. Asia Pac J Clin Nutr. 2008; 17:285-9.]Search in Google Scholar
[40. Palli D, Decarli A, Russo A, Cipriani F, Giacosa A, Amadori D, et al. Plasma levels of antioxidant vitamins and cholesterol in a large population sample in centralnorthern Italy. Eur J Nutr. 1999; 38:90-8.10.1007/s00394005004910352948]Open DOISearch in Google Scholar